NCT03953976View on ClinicalTrials.gov

INRT-AIR: A Prospective Phase II Study of Involved Nodal Radiation Therapy

PHASE2CompletedINTERVENTIONAL
Enrollment

67

Participants

Timeline

Start Date

July 23, 2019

Primary Completion Date

November 15, 2022

Study Completion Date

January 22, 2024

Conditions
Head and Neck Squamous Cell Carcinoma
Interventions
RADIATION

Intensity modulated radiation therapy (IMRT)

Intensity modulated radiation therapy (IMRT) with or without chemotherapy (if given, either cisplatin, cetuximab, or carboplatin-paclitaxel). 6.5-7 weeks of radiotherapy or chemoradiotherapy

Trial Locations (1)

75390

University of Texas Southwestern Medical Center - Dallas, Dallas

All Listed Sponsors
lead

University of Texas Southwestern Medical Center

OTHER

NCT03953976 - INRT-AIR: A Prospective Phase II Study of Involved Nodal Radiation Therapy | Biotech Hunter | Biotech Hunter